HPV vaccine

Global Pediatric Vaccine Market 2020-2025 - Rising Number of Collaborations, Expansions, and Mergers

Retrieved on: 
Monday, January 4, 2021
Medical specialties, Medicine, Clinical medicine, Vaccines, Vaccine, Virology, Vaccination, Preventive healthcare, Immunization, Vaccine hesitancy, HPV vaccine

Certain factors, such as the rising number of chronic diseases across the globe along with the initiatives taken by the Governments towards promoting vaccination have been major drivers of growth for the pediatric market.

Key Points: 
  • Certain factors, such as the rising number of chronic diseases across the globe along with the initiatives taken by the Governments towards promoting vaccination have been major drivers of growth for the pediatric market.
  • Additionally, increasing awareness about the importance of pediatric vaccination in the prevention of diseases is expected to fuel market growth.
  • However, the costs attached to immunization and the low level of accessibility in low-income countries restrain the growth of this market.
  • By Vaccine Type, the Monovalent Vaccine is estimated to account for the fastest-growing segment during the forecast period.

Global Oncology Launches Vaccine Education Campaign to Eradicate Cervical Cancer, Appointing Nigerian Stock Exchange President as Global Ambassador

Retrieved on: 
Monday, December 21, 2020
Infectious diseases, Pharmaceutical, Health, Oncology, Cancer, Clinical medicine, Medicine, Infectious causes of cancer, Papillomavirus, Gynaecological cancer, Vaccines, Cancer vaccines, HPV vaccine, Cervical cancer, Global Oncology, Vaccine

Global Oncology, a U.S.-based non-profit organization announces the launch of the Cervical Cancer-Free Nigeria (CCFN) campaign, which seeks to eradicate virus-driven diseases such as cervical cancer by educating Nigerians about vaccine safety and efficacy.

Key Points: 
  • Global Oncology, a U.S.-based non-profit organization announces the launch of the Cervical Cancer-Free Nigeria (CCFN) campaign, which seeks to eradicate virus-driven diseases such as cervical cancer by educating Nigerians about vaccine safety and efficacy.
  • View the full release here: https://www.businesswire.com/news/home/20201221005135/en/
    Mr. Abimbola Ogunbanjo, President of the Nigerian Stock Exchange (Photo: Business Wire)
    Im proud to partner with Global Oncology in advancing the CCFN campaign, said Otunba Ogunbanjo.
  • The success of the HPV vaccine campaign and recently initiated COVID-19 vaccine efforts depend on the general public being made aware of vaccine safety, efficacy and availability.
  • This is the mission of the CCFN campaign: to ensure that no Nigerian woman dies of cervical cancer.

Human Vaccines Market Clock CAGR of 8.7% from 2019 to 2027, Rich Pipeline for Meningococcal Vaccines Spur Revenue Streams: TMR

Retrieved on: 
Thursday, December 17, 2020
Medical specialties, Medicine, Health, Vaccines, Virology, Vaccine, Vaccination, Immunization, HPV vaccine, Vaccine hesitancy

Adoption of routine childhood immunization in numerous economies has spurred strides in the human vaccines market.

Key Points: 
  • Adoption of routine childhood immunization in numerous economies has spurred strides in the human vaccines market.
  • Rising numbers of childhood immunization programs in developing and developed nations have expanded the market outlook of human vaccines market.
  • Education about the benefits of vaccination programs in pediatric population has boosted the uptake in the human vaccine market.
  • Nevertheless, the growing health burden of infectious diseases, recently COVID-19, has spurred vaccine makers to augment their stakes in the human vaccines market.

Human Vaccines Market Clock CAGR of 8.7% from 2019 to 2027, Rich Pipeline for Meningococcal Vaccines Spur Revenue Streams: TMR

Retrieved on: 
Thursday, December 17, 2020
Medical specialties, Medicine, Health, Vaccines, Virology, Vaccine, Vaccination, Immunization, HPV vaccine, Vaccine hesitancy

Adoption of routine childhood immunization in numerous economies has spurred strides in the human vaccines market.

Key Points: 
  • Adoption of routine childhood immunization in numerous economies has spurred strides in the human vaccines market.
  • Rising numbers of childhood immunization programs in developing and developed nations have expanded the market outlook of human vaccines market.
  • Education about the benefits of vaccination programs in pediatric population has boosted the uptake in the human vaccine market.
  • Nevertheless, the growing health burden of infectious diseases, recently COVID-19, has spurred vaccine makers to augment their stakes in the human vaccines market.

Approximately 12 Million Blacks Say They Will Take the Vaccine. Here's Why!

Retrieved on: 
Wednesday, December 16, 2020
Vaccines, Medical specialties, Vaccination, Vaccine, Virology, Medicine, Clinical medicine, Medical research, Influenza vaccine, HPV vaccine

This study asked Black Americans what might boost their confidence for taking the vaccine?

Key Points: 
  • This study asked Black Americans what might boost their confidence for taking the vaccine?
  • Sixty percent (60%) said they will not be taking the vaccine.
  • Among the remaining 40% of responses, 17.4 % selected "The OK from top black doctors" as the top confidence booster.
  • All responses are listed in order below:
    Again, the study reported approximately 60% still are reluctant to take the vaccine.

World Vaccines Market Analysis, Players, Trends Report 2020 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 15, 2020
Health, Pharmaceutical, Medical specialties, Medicine, Health sciences, Vaccination, Virology, Medical research, Vaccine, COVID-19 vaccine, Vaccines, Gavi, HPV vaccine

The "Vaccines 2020: World Market Analysis, Players, Trends" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Vaccines 2020: World Market Analysis, Players, Trends" report has been added to ResearchAndMarkets.com's offering.
  • This report examines the market for these vaccines used to prevent various types of disease, and provides market modeling by disease.
  • The report also discusses trends and looks at what vaccine companies have done and are planning.
  • It also covers the COVID-19 vaccine market landscape, development progress and estimated market opportunity as of October 2020.

MyMedBot launches COVID-19 vaccine management solution for businesses and schools

Retrieved on: 
Friday, December 11, 2020
Medical specialties, Clinical medicine, Immune system, Immunization, Vaccination, Vaccines, Health observances, HPV vaccine, Vaccination policy

The current MyMedBot platform has already been used to conduct more than 2.5 million health screenings for over 180 organizations across the USA and Canada.

Key Points: 
  • The current MyMedBot platform has already been used to conduct more than 2.5 million health screenings for over 180 organizations across the USA and Canada.
  • Yet, it is not clear how the vaccine will be distributed and how individual immunization status will be verified.
  • With the MyMedBot health screening solution, organizations will be able to decide what information is to be provided by their community members and what vaccination verification proof is required.
  • MyMedBot is a digital health start-up based in Luxembourg, which provides health screening software for schools and businesses across the US, Canada, Europe and the Middle East.

Report: Nearly Half Of Health Center Patients Qualify For Phase One COVID Vaccinations

Retrieved on: 
Wednesday, December 9, 2020
Health sciences, Medicine, Health, COVID-19 vaccine, Medical research, Vaccine, Vaccines, Vaccination, Centers for Disease Control and Prevention, Preventive healthcare, Influenza vaccine, HPV vaccine

BETHESDA, Md., Dec. 9, 2020 /PRNewswire/ -- Nearly half of all patients that Community Health Centers serve qualify for Phase One COVID-19 immunizations under priority guidelines established by the Centers for Disease Control and Prevention (CDC) according to a new report.

Key Points: 
  • BETHESDA, Md., Dec. 9, 2020 /PRNewswire/ -- Nearly half of all patients that Community Health Centers serve qualify for Phase One COVID-19 immunizations under priority guidelines established by the Centers for Disease Control and Prevention (CDC) according to a new report.
  • Health centers are positioned to play a major role in ensuring the COVID-19 vaccine reaches high-risk populations.
  • Health centers serve urban, rural, and frontier communities that otherwise face significant barriers to care, which is particularly problematic for vaccines requiring two different clinical visits.
  • Protecting health center workers on the front lines is also a vital concern as 22,751 health center staff have already been infected by the virus.Assuming health centers provide two dose vaccines to all health center staff, their 30 million patients, and many additional community residents, preliminary estimates of vaccinations and related costs are at least $2.73 billion.

New Study Identifies Challenges for COVID-19 Vaccine Adoption

Retrieved on: 
Friday, December 4, 2020
Medical specialties, Medicine, Medical research, Virology, Health sciences, COVID-19 vaccine, Vaccine, Vaccination, Vaccines, Influenza vaccine, HPV vaccine

Last month, Dr. Anthony Fauci said, "We know what the efficacy of the vaccines are, but its effectiveness will depend on how many people take the vaccine."

Key Points: 
  • Last month, Dr. Anthony Fauci said, "We know what the efficacy of the vaccines are, but its effectiveness will depend on how many people take the vaccine."
  • Avenue Group's research identified several areas that need to be addressed to increase the vaccination adoption rate.
  • Avenue Group Founder Jeremy Greenberg said, "Only half of participants told us that they are likely to take a COVID-19 vaccine.
  • The findings from this small study should be considered directional as this was not a large population study, and we prioritized deeper, live interactions over sample size.

Gardasil Attorneys Allege HPV Vaccine Caused Girl to Develop POTS

Retrieved on: 
Wednesday, November 18, 2020
Vaccination, Papillomavirus, Clinical medicine, Vaccines, Medical specialties, Cancer vaccines, Infectious causes of cancer, Gardasil, HPV vaccine, Vaccine, Human papillomavirus infection

The plaintiff in the case, Sahara Walker of Lake Mills, Wisconsin, received the Gardasil vaccine when she was just 11 years old.

Key Points: 
  • The plaintiff in the case, Sahara Walker of Lake Mills, Wisconsin, received the Gardasil vaccine when she was just 11 years old.
  • Ms. Walker is seeking punitive damages against Merck for creating a substantial risk of significant harm to children and patients who were injected with the Gardasil HPV vaccine .
  • Attorneys representing Sahara Walker further allege that Gardasil contains a secret DNA adjuvant and potentially hazardous ingredient designed to make the vaccine more potent.
  • But since she became sick and disabled within days of getting the shot, we firmly believe her adverse reactions were caused by the Gardasil vaccine.